Delivery Order SPE2DX22D0010-SPE2D825FHA77
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,575.92 to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price, competitively awarded delivery order was issued under a non-set-aside procurement to the pharmaceutical distributor's Corporate Office division, based in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $573,801.20 to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order, issued without a set-aside designation, was competitively awarded to AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1.9 million to AmerisourceBergen Drug Corp on July 18, 2025, with a completion date of July 21, 2025. This firm fixed-price delivery order, issued without set-aside designation, is performed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a leading pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a comprehensive range of medical products...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $13,834.79 to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contractor,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,392.44 to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply products. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $388,548.82 to AmerisourceBergen Drug Corp on July 18, 2025, with a completion date of July 21, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The delivery order will be performed at the contractor's Corporate Office location in...
- The Defense Logistics Agency Medical Supply Chain awarded a $3,950.10 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation and specifies...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,309.48 to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor for pharmaceutical products and medical supplies supporting federal medical procurement needs. The contract is performed at AmerisourceBergen's corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,523.65 to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of the same day. This firm fixed-price delivery order, issued without set-aside designation, represents a small-value pharmaceutical procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $77,125.06 to AmerisourceBergen Drug Corp on July 18, 2025, for pharmaceutical products and medical supplies. This firm fixed price delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation and...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHA77Delivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $43,436.25 to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price, non-set-aside delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX, a $1 billion comprehensive pharmaceutical support vehicle that runs through December 2026. The delivery order represents a child contract under this prime indefinite delivery vehicle, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen has demonstrated capability to meet federal procurement requirements through competitive award processes. The company serves critical federal customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order is part of the DLA Troop Support's broader Pharmaceutical Prime Vendor Global Program strategy, which is structured to support military medical supply chains and healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.4k | 7/18/25 |